Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 27Anemia, Refractory, with Excess of Blasts 27Myelodysplastic Syndromes 22Myeloproliferative Disorders 14Venous Thromboembolism 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasms 11Lymphoma, Non-Hodgkin 11Leukemia, Myelomonocytic, Chronic 10Anemia 10Primary Myelofibrosis 9Hematologic Neoplasms 9Anemia, Aplastic 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Thrombocytopenia 7Multiple Myeloma 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Febrile Neutropenia 6Fanconi Anemia 6Congenital Bone Marrow Failure Syndromes 6Venous Thrombosis 5Pulmonary Embolism 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Follicular 5Anemia, Sickle Cell 5Recurrence 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4

Interventions

oprelvekin 1Interleukin-11 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
CTIT: Cancer Therapy Induced Thrombocytopenia × Classical hematology × 90 days × Clear all
NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting
88 enrolled
Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡